• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局灶性喉肌张力障碍的临床及实验室特征:110例研究

Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases.

作者信息

Blitzer A, Brin M F, Fahn S, Lovelace R E

机构信息

Department of Otolaryngology, Dystonia Clinical Research Center, Columbia-Presbyterian Medical Center, New York, NY.

出版信息

Laryngoscope. 1988 Jun;98(6 Pt 1):636-40. doi: 10.1288/00005537-198806000-00012.

DOI:10.1288/00005537-198806000-00012
PMID:3374239
Abstract

Spastic dysphonia is a syndrome often producing a strain-strangle voice. We have previously classified most of these patients as having focal laryngeal dystonia, a disorder of central motor processing. In a study of 1,280 cases of dystonia registered at the Dystonia Clinical Research Center at the Columbia-Presbyterian Medical Center, we found 110 patients who had vocal cord involvement. These patients had historical information evaluated for age of onset (mean 34.6 years), duration of symptoms (mean 13.8 years), sex (1.4:1 female to male) family history (positive in 23%), and primary (66%) and secondary (34%) etiology; neurological evaluation for other dystonic involvement (25% with segmental cranial involvement, 23% with generalized dystonia) or tremor (irregular 23%, regular 6% on EMG). Treatment options were evaluated and included speech therapy, psychotherapy, biofeedback (with limited success), systemic medication (limited success except in abductor cases), nerve section (with late failure rate), and the use of botulinum toxin (improvement in all 34 injected patients).

摘要

痉挛性发音障碍是一种常导致紧张性发声困难的综合征。我们之前将大多数这类患者归类为患有局灶性喉肌张力障碍,这是一种中枢运动处理障碍。在对哥伦比亚长老会医学中心肌张力障碍临床研究中心登记的1280例肌张力障碍病例进行的一项研究中,我们发现110例患者存在声带受累。这些患者的病史信息评估了发病年龄(平均34.6岁)、症状持续时间(平均13.8年)、性别(女性与男性比例为1.4:1)、家族史(23%呈阳性)以及原发性(66%)和继发性(34%)病因;还进行了神经系统评估,以确定是否存在其他肌张力障碍受累情况(25%有节段性颅部受累,23%有全身性肌张力障碍)或震颤(肌电图显示不规则震颤占23%,规则震颤占6%)。对治疗方案进行了评估,包括言语治疗、心理治疗、生物反馈(效果有限)、全身用药(除外展型病例外效果有限)、神经切断术(后期失败率较高)以及肉毒杆菌毒素的使用(所有34例接受注射的患者均有改善)。

相似文献

1
Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases.局灶性喉肌张力障碍的临床及实验室特征:110例研究
Laryngoscope. 1988 Jun;98(6 Pt 1):636-40. doi: 10.1288/00005537-198806000-00012.
2
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).局部注射肉毒杆菌毒素治疗局灶性喉肌张力障碍(痉挛性发声障碍)。
Laryngoscope. 1988 Feb;98(2):193-7. doi: 10.1288/00005537-198802000-00015.
3
[Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].[肉毒杆菌毒素。痉挛性发声障碍(喉外展肌肌张力障碍)的一种新的治疗选择]
Tidsskr Nor Laegeforen. 1993 Mar 10;113(7):841-3.
4
[Adduction spastic dysphonia: clinical and treatment].[内收型痉挛性发声障碍:临床与治疗]
Rev Clin Esp. 1998 Mar;198(3):156-8.
5
Clinical characteristics of essential voice tremor: a study of 34 cases.特发性声带震颤的临床特征:34 例研究。
Laryngoscope. 2010 Mar;120(3):516-28. doi: 10.1002/lary.20702.
6
[Indications for botulinum toxin in laryngectomy].[喉切除术中肉毒杆菌毒素的适应证]
Rev Laryngol Otol Rhinol (Bord). 1993;114(4):281-7.
7
Abductor laryngeal dystonia: a series treated with botulinum toxin.喉外展肌肌张力障碍:肉毒杆菌毒素治疗的病例系列
Laryngoscope. 1992 Feb;102(2):163-7. doi: 10.1288/00005537-199202000-00011.
8
[Primary focal dystonia: descriptive study of 205 patients].[原发性局灶性肌张力障碍:205例患者的描述性研究]
Neurologia. 2003 Mar;18(2):59-65.
9
Electromyographic findings in focal laryngeal dystonia (spastic dysphonia).局灶性喉肌张力障碍(痉挛性发声障碍)的肌电图检查结果
Ann Otol Rhinol Laryngol. 1985 Nov-Dec;94(6 Pt 1):591-4. doi: 10.1177/000348948509400614.
10
Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.肉毒杆菌毒素注射治疗痉挛性发声障碍:诗里拉医院的经验
J Med Assoc Thai. 2006 Dec;89(12):2077-80.

引用本文的文献

1
Demographic and clinical characteristics of our patients diagnosed with laryngeal dystonia.我们诊断为喉肌痉挛患者的人口统计学和临床特征。
Eur Arch Otorhinolaryngol. 2024 Aug;281(8):4265-4271. doi: 10.1007/s00405-024-08688-9. Epub 2024 May 7.
2
Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study.《肉毒毒素 A 在声带痉挛患者中的安全性和有效性:52 周多中心上市后监测研究的最终报告》。
Toxins (Basel). 2023 Sep 5;15(9):553. doi: 10.3390/toxins15090553.
3
Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia.
肉毒毒素神经毒素疗法在喉部肌张力障碍的临床治疗中的应用。
Toxins (Basel). 2022 Dec 1;14(12):844. doi: 10.3390/toxins14120844.
4
Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update.肉毒杆菌毒素治疗日本痉挛性发音障碍:历史与更新。
Toxins (Basel). 2022 Jul 1;14(7):451. doi: 10.3390/toxins14070451.
5
Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan.肉毒杆菌毒素治疗:日本痉挛性发声障碍患者的一系列临床研究。
Toxins (Basel). 2021 Nov 25;13(12):840. doi: 10.3390/toxins13120840.
6
Post-treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo-controlled, randomized, double-blinded clinical trial in Japan.肉毒杆菌毒素注射疗法治疗内收型痉挛性发声障碍后的治疗后临床过程:来自日本一项安慰剂对照、随机、双盲临床试验的数据分析。
Laryngoscope Investig Otolaryngol. 2021 Sep 28;6(5):1088-1095. doi: 10.1002/lio2.669. eCollection 2021 Oct.
7
Thalamic Deep Brain Stimulation for Spasmodic Dysphonia: A Phase I Prospective Randomized Double-Blind Crossover Trial.丘脑深部脑刺激治疗痉挛性发声障碍:一项 I 期前瞻性随机双盲交叉试验。
Neurosurgery. 2021 Jun 15;89(1):45-52. doi: 10.1093/neuros/nyab095.
8
Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo-controlled, randomized, double-blinded, parallel-group comparison/open-label clinical trial.肉毒毒素注射至喉内肌治疗痉挛性发声障碍:一项多中心、安慰剂对照、随机、双盲、平行组比较/开放标签临床试验。
Eur J Neurol. 2021 May;28(5):1548-1556. doi: 10.1111/ene.14714. Epub 2021 Jan 23.
9
Demographics and coexisting tremor, cervical dystonia and vocal fold disorders in a group of patients with spasmodic dysphonia.一组痉挛性发音障碍患者的人口统计学特征以及共存的震颤、颈部肌张力障碍和声带疾病
Acta Otorhinolaryngol Ital. 2020 Jun;40(3):198-203. doi: 10.14639/0392-100X-N0284.
10
The Effect of Octanoic Acid on Essential Voice Tremor: A Double-Blind, Placebo-Controlled Study.辛酸对原发性声音震颤的影响:一项双盲、安慰剂对照研究。
Laryngoscope. 2019 Aug;129(8):1882-1890. doi: 10.1002/lary.27695. Epub 2018 Dec 25.